Citius Pharmaceuticals (CTXR) Technical (Analysis) Reports Citius Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Citius Pharmaceuticals (CTXR)
Technical Analysis Report for NASDAQ stock CTXR Citius Pharmaceuticals. Dated: 26 Aug 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock CTXR Citius Pharmaceuticals then click here. or read Experts views on Citius Pharmaceuticals or Forecast & share price targets of Citius Pharmaceuticals
Citius Pharmaceuticals Opened at 0.60 and Closed at: 0.58, which is -3.45% of previous session's close. It moved within a range of 0.57 and 0.61
The session was a Bearish session with an average volume of 442800, which is -388.23% of previous session's volumes.
A Dead cross was found 2 days back on short term averages
Support for tomorrow is 0.56 and resistance for tomorrow is 0.6
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.56, 0.55 resistance for tomorrow's hourly charts is 0.6, 0.63
10 Day SMA for Citius Pharmaceuticals (CTXR) is 0.62 and stock is trading below these levels. This is not a good sign for its short term trend
20 Day SMA for Citius Pharmaceuticals (CTXR) is 0.65 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Citius Pharmaceuticals (CTXR) is 0.59 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.64 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Citius Pharmaceuticals is 0.77 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Citius Pharmaceuticals is at 0.65 and 200 DMA is at 0.77, while 50 DMA and 100 DMA are at 0.59 and 0.64 respectively
Citius Pharmaceuticals (CTXR) moving average of 20 SMA is at 0.65 and 20 EMA is at 0.63
| Date | Closing Price | 20 SMA | 20 EMA |
| 26 Wed Aug | 0.58 | 0.65 | 0.63 |
| 25 Tue Aug | 0.60 | 0.65 | 0.63 |
| 24 Mon Aug | 0.58 | 0.64 | 0.63 |
| 21 Fri Aug | 0.60 | 0.64 | 0.63 |
| 20 Thu Aug | 0.60 | 0.63 | 0.63 |
| 19 Wed Aug | 0.64 | 0.63 | 0.63 |
Citius Pharmaceuticals (CTXR) moving average of 50 SMA is at 0.59 and 50 EMA is at 0.64
| Date | Closing Price | 50 SMA | 50 EMA |
| 26 Wed Aug | 0.58 | 0.59 | 0.64 |
| 25 Tue Aug | 0.60 | 0.59 | 0.64 |
| 24 Mon Aug | 0.58 | 0.59 | 0.64 |
| 21 Fri Aug | 0.60 | 0.59 | 0.64 |
| 20 Thu Aug | 0.60 | 0.59 | 0.64 |
| 19 Wed Aug | 0.64 | 0.58 | 0.64 |
Citius Pharmaceuticals (CTXR) moving average of 100 SMA is at 0.64 and 100 EMA is at 0.75
| Date | Closing Price | 100 SMA | 100 EMA |
| 26 Wed Aug | 0.58 | 0.64 | 0.75 |
| 25 Tue Aug | 0.60 | 0.64 | 0.75 |
| 24 Mon Aug | 0.58 | 0.64 | 0.75 |
| 21 Fri Aug | 0.60 | 0.64 | 0.75 |
| 20 Thu Aug | 0.60 | 0.65 | 0.75 |
| 19 Wed Aug | 0.64 | 0.65 | 0.75 |
Citius Pharmaceuticals (CTXR) moving average of 200 SMA is at 0.77 and 200 EMA is at 1
| Date | Closing Price | 200 SMA | 200 EMA |
| 26 Wed Aug | 0.58 | 0.77 | 1 |
| 25 Tue Aug | 0.60 | 0.77 | 1 |
| 24 Mon Aug | 0.58 | 0.78 | 1 |
| 21 Fri Aug | 0.60 | 0.78 | 1 |
| 20 Thu Aug | 0.60 | 0.79 | 1 |
| 19 Wed Aug | 0.64 | 0.79 | 1 |
Xenon Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Xenon Pharmaceuticals, about 7.32% more returns!
United Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in United Therapeutics, about 6.2% more returns!
Tandem Diabetes has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Tandem Diabetes, about 20.35% more returns!
Supernus Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Supernus Pharmaceuticals, about 6.34% more returns!
Citius Pharmaceuticals has performed better than Sutro Biopharma in short term. Holding Citius Pharmaceuticals could be a better choice for now!
Si Bone has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Si Bone, about 15.94% more returns!
Radnet Inc has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Radnet Inc, about 29.92% more returns!
Neogenomics Inc has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Neogenomics Inc, about 17.32% more returns!
Lexicon Pharmaceuticals has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Lexicon Pharmaceuticals, about 6.66% more returns!
Exelixis Inc has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Exelixis Inc, about 8.17% more returns!
Equillium Inc has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Equillium Inc, about 9.66% more returns!
Ensign Group has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Ensign Group, about 8.95% more returns!
Editas Medicine has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Editas Medicine, about 26.16% more returns!
Capricor Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Capricor Therapeutics, about 131.33% more returns!
Autolus Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Autolus Therapeutics, about 60.23% more returns!
Amgen Inc has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Amgen Inc, about 21.54% more returns!
Allogene Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Allogene Therapeutics, about 11.49% more returns!
Abeona Therapeutics has performed better than Citius Pharmaceuticals in short term. You could have earned much better returns by investing in Abeona Therapeutics, about 0.83% more returns!
Citius Pharmaceuticals Technical analysis of indicators
Price action analysis of Citius Pharmaceuticals (CTXR) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Citius Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Citius Pharmaceuticals in short term and the sell signal is strong.
Citius Pharmaceuticals Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Citius Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term but selling is losing momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Citius Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.62 and Citius Pharmaceuticals CTXR stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Citius Pharmaceuticals CTXR stock. Volume based technical analysis of Citius Pharmaceuticals CTXR stock is negative.
Citius Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock CTXR Citius Pharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And CTXR Experts View which covers a lot of information including buying and selling signals
CTXR future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Citius Pharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Citius Pharmaceuticals (CTXR) Technical (Analysis) Reports Citius Pharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance


